Pre-eclampsia, a condition that causes dangerously high blood pressure, is a leading cause of death among mothers and babies.

(CBS News) Many doctors recommend that patients take a daily dose of aspirin to reduce their risk for a future heart attack or stroke. Now three new studies suggest taking the cheap powdery pill every ...

A new study says more people take daily aspirin than actually need it. — -- If you're taking aspirin to prevent heart attack and stroke, there's a chance you may not need to be popping the little ...

A government task force says a daily low-dose aspirin could help certain people in their 50s and 60s prevent a first heart attack or stroke - and they might get some protection against colon cancer at ...

For adults who have survived a heart attack or stroke, taking aspirin regularly may reduce the risk of another cardiovascular event. But a new study suggests that less than half of these ...

Aspirin remains one of the most inexpensive drugs in the pharmacy. A familiar brand name tablet costs less than 6 cents a pill. A bottle containing 300 tablets will set you back under $17. Despite the ...

Aspirin is one of the most commonly used medications in the U.S. Studies show that more than 40% of adults ages 60 or older take an aspirin every day to prevent dangerous blood clots that could lead ...

Based on new evidence, the U.S. Preventive Services Task Force says daily low-dose aspirin in people 60 years old or older has no net benefit due to an increased risk of bleeding. Evidence now ...

Does 2020 make you want to take an aspirin? Well, a study just published the journal Anesthesia and Analgesia is suggesting that taking low-dose aspirin could potentially, possibly, maybe have a ...

For patients who have undergone successful catheter ablation for atrial fibrillation, treatment with rivaroxaban does not offer superior stroke protection versus aspirin.

Laboratory and epidemiologic data suggest that aspirin has an antineoplastic effect in the large bowel. We performed a randomized, double-blind trial of aspirin as a chemopreventive agent against ...